Comprehensive re-assessment of plasma VEGFA (pVEGFA) as a candidate predictive biomarker for bevacizumab (Bv) in thirteen pivotal trials (seven indications)
ANGIOGENESIS（2014）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined